MIREN
ZULAICA IJURCO
Investigadora hasta 2022
![Foto de MIREN](/img/nophoto.png)
![Foto de Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas](/img/noimage_org.png)
Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (21)
2023
2022
-
Genome-wide meta-analysis for Alzheimer’s disease cerebrospinal fluid biomarkers
Acta Neuropathologica, Vol. 144, Núm. 5, pp. 821-842
-
New insights into the genetic etiology of Alzheimer's disease and related dementias
Nature genetics, Vol. 54, Núm. 4, pp. 412-436
-
Senescence plays a role in myotonic dystrophy type 1
JCI insight, Vol. 7, Núm. 19
2021
-
Common variants in Alzheimer's disease and risk stratification by polygenic risk scores
Nature communications, Vol. 12, Núm. 1, pp. 3417
-
Description of Two Families with New Mutations in Familial Cerebral Cavernous Malformations Genes
Journal of Stroke and Cerebrovascular Diseases, Vol. 30, Núm. 12
2020
-
A comprehensive serum lipidome profiling of amyotrophic lateral sclerosis
Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, Vol. 21, Núm. 3-4, pp. 252-262
-
A deep intronic splice variant advises reexamination of presumably dominant SPG7 Cases
Annals of Clinical and Translational Neurology, Vol. 7, Núm. 1, pp. 105-111
-
Age-related cognitive decline in myotonic dystrophy type 1: An 11-year longitudinal follow-up study
Journal of Neuropsychology, Vol. 14, Núm. 1, pp. 121-134
-
Correction to: A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer’s disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity (Acta Neuropathologica, (2019), 138, 2, (237-250), 10.1007/s00401-019-02026-8)
Acta Neuropathologica
-
Metabolic alterations in plasma from patients with familial and idiopathic Parkinson's disease
Aging, Vol. 12, Núm. 17, pp. 16690-16708
-
Neurodegeneration trajectory in pediatric and adult/late DM1: A follow-up MRI study across a decade
Annals of Clinical and Translational Neurology, Vol. 7, Núm. 10, pp. 1802-1815
-
Phenotypic correlations in a large single-center cohort of patients with BSCL2 nerve disorders: a clinical, neurophysiological and muscle magnetic resonance imaging study
European Journal of Neurology, Vol. 27, Núm. 8, pp. 1364-1373
-
Sequential targeted exome sequencing of 1001 patients affected by unexplained limb-girdle weakness
Genetics in Medicine, Vol. 22, Núm. 9, pp. 1478-1488
-
Targeted next-generation sequencing in a large cohort of genetically undiagnosed patients with neuromuscular disorders in Spain
Genes, Vol. 11, Núm. 5
2019
-
Increased Muscleblind levels by chloroquine treatment improve myotonic dystrophy type 1 phenotypes in in vitro and in vivo models
Proceedings of the National Academy of Sciences of the United States of America, Vol. 116, Núm. 50, pp. 25203-25213
-
Nonsense mutations in alpha-II spectrin in three families with juvenile onset hereditary motor neuropathy
Brain, Vol. 142, Núm. 9, pp. 2605-2616
-
Parkinsonism and spastic paraplegia type 7: Expanding the spectrum of mitochondrial Parkinsonism
Movement Disorders, Vol. 34, Núm. 10, pp. 1547-1561
-
Regional brain atrophy in gray and white matter is associated with cognitive impairment in Myotonic Dystrophy type 1
NeuroImage: Clinical, Vol. 24
2018
-
Blood Markers in Healthy-Aged Nonagenarians: A Combination of High Telomere Length and Low Amyloidβ Are Strongly Associated With Healthy Aging in the Oldest Old
Frontiers in Aging Neuroscience, Vol. 10